Raaj Medisafe India Ltd

Raaj Medisafe India Ltd

$RAAJMEDIPackagingBSE

Raaj Medisafe India Ltd (RAAJMEDI) last traded at ₹80, a market capitalisation of ₹131 crore, on a P/E of 55.7. Over the past 52 weeks the stock has ranged between ₹64.1 and ₹96. Raaj Medisafe India Ltd last reported results for the quarter ended Jun 2026, with sales of ₹29.46 crore and net profit of ₹1.97 crore. Raaj Medisafe India Ltd’s annual general meeting is scheduled for 21 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Raaj Medisafe India Ltd share price and key metrics

Current price
₹80
Market cap
₹131 cr
Stock P/E
55.7
Book value
₹28.5
ROE
4.91%
ROCE
11.9%
Dividend yield
0.00%
52w high / low
96.0/64.1

Metrics as of 25 Aug 2026. Not real time.

Raaj Medisafe India Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹29.46 cr, up 86.1% from ₹15.83 cr a year earlier. Net profit was ₹1.97 cr, up 34.9% year on year.

Raaj Medisafe India Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales10.9114.5924.415.8318.420.7125.0829.46
Expenses9.1812.3721.2913.2115.6517.0222.3725.4
Operating profit1.732.223.112.622.753.692.714.06
OPM %15.86%15.22%12.75%16.55%14.95%17.82%10.81%13.78%
Other income0-0.010.110.010.230.040.280.15
Interest0.360.520.680.680.821.381.080.86
Depreciation0.230.40.440.490.430.50.630.71
Profit before tax1.141.292.11.461.731.851.282.64
Tax %15.79%19.38%-65.24%0.00%0.00%-2.70%353.12%25.00%
Net profit0.971.033.481.461.731.89-3.231.97
EPS (₹)0.730.782.631.111.321.44-1.971.20

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Raaj Medisafe India Ltd annual results

Raaj Medisafe India Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales31.834.6838.6143.2462.4280.0193.65
Operating profit4.065.085.616.648.6311.7613.21
OPM %12.77%14.65%14.53%15.36%13.83%14.70%14.11%
Net profit2.33.013.333.336.131.812.36
EPS (₹)2.102.753.043.044.641.101.99

TTM is the trailing twelve months to the most recent quarter.

Raaj Medisafe India Ltd growth and returns

Compounded Sales Growth
10 Years
46%
5 Years
20%
3 Years
27%
TTM
42%
Compounded Profit Growth
10 Years
14%
5 Years
-5%
3 Years
-18%
TTM
-66%
Stock Price CAGR
10 Years
27%
5 Years
19%
3 Years
33%
1 Year
-5%
Return on Equity
10 Years
%
5 Years
24%
3 Years
17%
Last Year
5%

Raaj Medisafe India Ltd shareholding pattern

Promoters held 59.08% at Jun 2026, down from 73.45% at Jun 2025.

Raaj Medisafe India Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters73.45%73.45%73.45%73.45%73.80%73.80%73.80%59.08%
Public26.55%26.56%26.55%26.55%26.20%26.20%26.19%40.92%
No. of shareholders8,1818,1518,1388,1417,8107,7817,7707,783

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Raaj Medisafe India Ltd’s AGM?

Raaj Medisafe India Ltd’s annual general meeting is scheduled for 21 Sept 2026.

  • AGM41st Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Raaj Medisafe India Ltd corporate filings

  • We submit herewith Newspaper cuttings related to publication of Unaudited Financial Results of the Company for the quarter ended June 30, 2026 published in Free Press and Chautha Sansar ....Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Raaj Medisafe India Limited has released its unaudited financial results for the quarter…

    Read the full analysis
  • We submit herewith Unaudited Financial Results for the Quarter ended June 30, 2026 together with Limited Review Report.Resulthigh impact
    Filing PDF

    Cruxal's analysis: Raaj Medisafe India Limited reported robust financial results for the quarter ended June…

    Read the full analysis
  • We submit herewith statement of Variation/deviation of utilization of Funds raised by way of Preferential Allotment on 26.03.2026Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Raaj Medisafe India Limited has filed its statement of deviation or variation for the…

    Read the full analysis
  • The Board of Directors of the Company in its meeting held on 12.08.2026 has appointed Mr. Vipul Parakh as Chief Financial officer of the Company.Company Updatelow impact
    Filing PDF

    Cruxal's analysis: Raaj Medisafe India Limited has announced the appointment of Mr. Vipul Parakh as the new…

    Read the full analysis
  • The Board of Directors in its meeting held on August 121, 2026 has inter-alia approved and taken on record Unaudited Financial Results for the quarter ended June 30, 2026. Details of other ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Raaj Medisafe India Limited has announced a leadership change with the resignation of Ms…

    Read the full analysis
  • Raaj Medisafe India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve A meeting of the Board ....Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Raaj Medisafe India Limited has scheduled a Board Meeting for August 12, 2026, to…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Raaj Medisafe India Ltd

Cruxal reads every Raaj Medisafe India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Raaj Medisafe India Ltd (RAAJMEDI) Results, Financials & Share Price | Cruxal